Abstract
This article provides a review of methods for conducting cost-effectiveness, cost-utility, and cost-benefit studies. Economic evaluations of interventions designed to improve outcomes of patients with diabetes and osteoporosis are reviewed, and key issues for future research are discussed. The role of cost-effectiveness analysis in reimbursement decision making at the public and private levels is explored.
MeSH terms
-
Cost-Benefit Analysis
-
Costs and Cost Analysis
-
Diabetes Mellitus / economics
-
Diabetes Mellitus / therapy
-
Diabetic Nephropathies / economics
-
Diabetic Nephropathies / therapy
-
Diabetic Retinopathy / economics
-
Diabetic Retinopathy / therapy
-
Endocrine System Diseases / economics
-
Endocrine System Diseases / therapy
-
Endocrinology / economics*
-
Humans
-
Osteoporosis / economics
-
Osteoporosis / therapy